Dryden Capital’s European Biotech Acquisition Corp. Warrant EBACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-15,000
Closed -$4.47K 39
2022
Q4
$4.47K Hold
15,000
0.01% 34
2022
Q3
$0 Hold
15,000
﹤0.01% 58
2022
Q2
$1K Hold
15,000
﹤0.01% 54
2022
Q1
$3K Hold
15,000
﹤0.01% 55
2021
Q4
$9K Buy
+15,000
New +$9K 0.01% 43